Preclinical Evaluation of a Trop2-Targeted Peptide Probe for PET Imaging of Triple-Negative Breast Cancer.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Preclinical Evaluation of a Trop2-Targeted Peptide Probe for PET Imaging of Triple-Negative Breast Cancer.
- Published In:
- Analytical chemistry, 97(42), 23598-23608 (2025)
- Authors:
- Zha, Yuan, Zhu, Xue, Xue, Yan(3), Huang, Zhihong, Wang, Shuang, Jiao, Yang, Chen, Yu, Yao, Ying, Wang, Ke, Fang, Jing
- Database ID:
- RPEP-14471
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-14471APA
Zha, Yuan; Zhu, Xue; Xue, Yan; Huang, Zhihong; Wang, Shuang; Jiao, Yang; Chen, Yu; Yao, Ying; Wang, Ke; Fang, Jing. (2025). Preclinical Evaluation of a Trop2-Targeted Peptide Probe for PET Imaging of Triple-Negative Breast Cancer.. Analytical chemistry, 97(42), 23598-23608. https://doi.org/10.1021/acs.analchem.5c05242
MLA
Zha, Yuan, et al. "Preclinical Evaluation of a Trop2-Targeted Peptide Probe for PET Imaging of Triple-Negative Breast Cancer.." Analytical chemistry, 2025. https://doi.org/10.1021/acs.analchem.5c05242
RethinkPeptides
RethinkPeptides Research Database. "Preclinical Evaluation of a Trop2-Targeted Peptide Probe for..." RPEP-14471. Retrieved from https://rethinkpeptides.com/research/zha-2025-preclinical-evaluation-of-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.